Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
J Physiol. 2021 Sep;599(18):4375-4388. doi: 10.1113/JP281834. Epub 2021 Aug 9.
The recurrent SCN2A mutation R853Q is associated with developmental and epileptic encephalopathy with typical onset after the first months of life. Heterologously expressed R853Q channels exhibit an overall loss-of-function as a result of multiple defects in time- and voltage-dependent channel properties. A previously unrecognized enhancement of slow inactivation is conferred by the R853Q mutation and is a major driver of loss-of-function. Enhanced slow inactivation is potentiated in the canonical splice isoform of the channel and this may explain the later onset of symptoms associated with R853Q.
Mutations in voltage gated sodium (Na ) channel genes, including SCN2A (encoding Na 1.2), are associated with diverse neurodevelopmental disorders with or without epilepsy that present clinically with varying severity, age-of-onset and pharmacoresponsiveness. We examined the functional properties of the most recurrent SCN2A mutation (R853Q) to determine whether developmentally-regulated alternative splicing impacts dysfunction severity and to investigate effects of the mutation on slow inactivation. We engineered the R853Q mutation into neonatal and adult Na 1.2 splice isoforms. Channel constructs were heterologously co-expressed in HEK293T cells with human β1 and β2 subunits. Whole-cell patch clamp recording was used to compare time- and voltage-dependent properties of mutant and wild-type channels. The R853Q mutation exhibits an overall loss-of-function attributed to multiple functional defects including a previously undiscovered enhancement of slow inactivation. The mutation exhibited altered voltage dependence of activation and inactivation, slower recovery from inactivation and decreased channel availability during high-frequency depolarizations. More notable were effects on slow inactivation, including a 10-fold slower rate of recovery from slow inactivation exhibited by mutant channels. The impairments in fast inactivation properties were more severe in the neonatal splice isoform, whereas slow inactivation was more pronounced in the splice isoform of the channel expressed predominantly in later childhood. Enhanced later-onset slow inactivation may be a primary driver of the later onset of neurological features associated with this mutation.
反复出现的 SCN2A 突变 R853Q 与典型发病于生命最初几个月后的发育性和癫痫性脑病相关。体外表达的 R853Q 通道由于时间和电压依赖性通道特性的多种缺陷而表现出整体功能丧失。先前未被认识到的慢失活增强由 R853Q 突变赋予,是功能丧失的主要驱动因素。在通道的规范剪接异构体中,慢失活增强被增强,这可能解释了与 R853Q 相关的症状出现较晚。
电压门控钠离子(Na + )通道基因(包括 SCN2A (编码 Na 1.2 ))的突变与伴有或不伴癫痫的多种神经发育障碍相关,其临床表现具有不同的严重程度、发病年龄和药物反应性。我们研究了最常见的 SCN2A 突变(R853Q)的功能特性,以确定发育调节的替代剪接是否影响功能障碍的严重程度,并研究该突变对慢失活的影响。我们将 R853Q 突变引入新生和成年 Na 1.2 剪接异构体。将通道构建体与人类β1和β2 亚基在 HEK293T 细胞中共表达。使用全细胞贴片钳记录来比较突变和野生型通道的时间和电压依赖性特性。R853Q 突变表现出整体功能丧失,归因于多种功能缺陷,包括先前未发现的慢失活增强。该突变表现出激活和失活的电压依赖性改变、失活恢复较慢以及在高频去极化期间通道可用性降低。更值得注意的是对慢失活的影响,包括突变通道表现出的慢失活恢复速度快 10 倍。在新生剪接异构体中,快速失活特性的损伤更严重,而在通道的剪接异构体中,在儿童后期主要表达的慢失活更为明显。增强的迟发性慢失活可能是与该突变相关的神经特征出现较晚的主要驱动因素。